The National Office of Animal Health Code of Practice Committee has found MSD Animal Health in breach of the NOAH Code on promotion for its advertisment for Equilis Prequenza.
The advert appeared in three separate issues of Veterinary Times (15, 22 and 29 September 2014), on the rear back cover of the 2014 BEVA Congress proceedings, and on the inside back cover of the 2014 Congress Planner. It contained the phrase “Neuraminidase antibodies provided a degree of protection in the case of HA strain/vaccine mismatch”, when viewed against the context of the advertisement headed ‘Why have part when you can have it all?”.
The Committee’s view was that the item in the context of the advertisement was intended to mean, and did convey, the meaning that the inclusion of NA antigens in an equine vaccine gave that vaccine a clinical advantage over vaccines which did not. This claim was not substantiated. Accordingly, the Committee found the phrase in breach of Code of Practice Clauses 4.1(iii) misleading, 4.1(vi) contained an exaggerated claim, 4.1(vii) implied it had a special merit which was not substantiated, 4.2(i) was not accurate and 4.2(ii) was not based upon an up-to-date evaluation of all the evidence.
Full details of the Committee’s rulings can be found on the NOAH website at www.noah.co.uk/code. The full report of this particular case will be available shortly.
Following a nationwide search to find the UK’s top veterinary professionals for 2008 and judged by an independent panel of experts, Petplan has announced the final short-list for the Petplan Veterinary Awards to be presented on 3rd April in Birmingham.
Those short-listed for the four categories of the Petplan Veterinary Awards acknowledging achievement in the veterinary world include:
Vet of the Year Brian Faulkner of the Melton Veterinary Surgery, Woodbridge Linda Glenn of the Glenn Veterinary Clinic, Bangor Girish Thakral of the Blacks Veterinary Group, Dudley
Vet Nurse of the Year Louisa Baker of the Priors Leaze Veterinary Centre, Chichester Alison Devonshire of the Orwell Veterinary Group, Ipswich Mark Vince of The Animal Clinic, Catford
Vet Receptionist of the Year Margaret Coupe of the Hedge End Veterinary Health Centre, Southampton Margaret Gait of Cinque Ports Veterinary Associates, Lydd Sandie Rule of the Eastcott Veterinary Clinic, Swindon
Vet Practice of the Year Battle Flatts Veterinary Clinic, York Orwell Veterinary Group, Ipswich Woodlands Veterinary Clinic, Cheltenham
Intervet/Schering-Plough Animal Health has announced the replacement of its Bovilis® IBR with Bovilis® IBR Marker Live vaccine, a move that brings the UK into line with the rest of Europe where marker vaccines are favoured.
Many EU member states, including Scandinavia and Austria are now declared IBR-free, and others (Germany and Hungary) operate national eradication programmes. Using a marker vaccine will help farmers wishing to export animals, or semen, or those working towards an eradication programme in their herds.
Recent bulk milk and blood screening via Intervet/Schering-Plough's complimentary BeefCheck and DairyCheck has revealed that 72% of herds tested were positive for IBR exposure. Given the latent nature of infection, and the rumbling losses associated with subclinical disease, it should come as no surprise that farmers are increasingly interested in controlling IBR. Studies have shown that IBR infection can result in a milk yield reduction of 173 litres per infected animal, or over £400 a year, for a 100-cow herd.
According to Intervet/Schering-Plough, Bovilis IBR Marker Live is Europe's leading IBR vaccine. It can be given intra-muscularly or intra-nasally to calves as young as two weeks old, as well as pregnant dams. It is also licensed to be given together with the pneumonia vaccine Bovilis® Bovipast RSP. The primary course involves one dose in cattle over three months of age, with immunity in just four days from the intra-nasal method, and 14 days from injection. Stock need re-vaccination every six months.
The vaccine reduces the amount of virus excreted into the environment, so minimising the risk to stressed cattle which may have been brought into the herd, and be latently infected. It also makes it an excellent choice for producers with breeding bulls, which should not be vaccinated. Bulls have to be kept naïve, however, the marker vaccine can be used on females in the herd to minimise virus circulation. This way the threat is minimised, and bulls can be kept infection free.
Elanco Companion Animal Health, maker of Comfortis and Trifexis, has launched Common parasites of dogs, a new publication designed to help veterinary professionals advising clients about the benefits of regular parasite control.
Focusing on endoparasites, the booklet includes information about roundworm (Toxocara canis and Toxascaris leonine), hookworm (Ancylostoma caninum), whipworm (Trichuris vulpis), heartworm (Dirofilaria immitis), lungworm (Angiostrongylus vasorum), tapeworm (Dipylidium caninum) and fleas (Ctenocephalides spp.). It includes details on the lifecycle of the parasites, how they develop, symptoms and sources of infection, whether the parasites are a risk to pets and humans and illustrations to explain their lifecycle and show what each of the parasites looks like.
Common parasites of dogs is available in two formats: a 'tablet friendly' electronic version and a booklet consisting of individual cards on a metal snap ring.
Matthew Rowe, senior brand manager at Elanco Companion Animal Health, said: "Pet owners often get confused by the different parasites that can be picked up by their dogs. The new common parasites of dogs education tool will help veterinary professionals advise their clients about parasites and the benefits of routine worming and flea treatments."
For a copy of Common parasites of dogs electronically or as a booklet, contact your Elanco Companion Animal Health key account manager or email elancoCAH.uk@elanco.com.
It is hoped the findings, which were unveiled at the House of Commons yesterday, will enable the welfare priorities of the UK’s 800,000 horses to be addressed.
This is the first time welfare organisations, breeders, the equine industry and the veterinary profession have come together to agree on a strategy to best improve the welfare of horses in the UK.
The equine welfare study found the welfare needs of many horses are not currently being met and the report has highlighted four welfare priorities.
Dr Siobhan Mullan, Research Fellow in Animal Welfare Science, Ethics and Law at the University of Bristol and one of the report’s authors, said: "Bringing together the views of people associated with horses in England and Wales has provided an overview of horse welfare, from the day-to-day concerns of equine caregivers to identifying four priority challenges to equine welfare.
"This research has also identified how equine welfare can be improved, by addressing both the priority challenges, and a wider set of industry and horse-based needs."
Roly Owers, World Horse Welfare Chief Executive, added: "This research report provides a vital insight to the UK’s equine sector, mapping out the welfare landscape from a wide range of sector experts and stakeholders.
"In order for World Horse Welfare and others to most effectively address the welfare challenges facing UK equines, we need to better understand today’s welfare priorities and this research will provide a valuable guide to help in driving the focus of our educational initiatives and resources over the next few years.”
The priority welfare challenges and solutions outlined in the report are:
Unresolved stress/pain behaviourProblems associated with unresolved stress/pain behaviour affect large numbers of horses, often for long durations with variable severity of suffering caused to individual horses.
More academic research is needed to fully understand the links between behaviour, stress and pain, and objective measures of stress and pain in horses should be developed. Vets, riding instructors, the Pony Club, riding clubs and the equine press have a role in educating horse caregivers about signs of stress and pain and the appropriate responses. Academics and experts also have a role in tackling this issue through evaluating the effectiveness of intervention programmes.
Inappropriate nutritionOverfeeding and obesity are the main welfare problems associated with nutrition and affect large numbers of horses, often for a long time with varying severity of suffering.
Vets have a key role in tackling the problems associated with inappropriate nutrition. A consistent approach by all vets is needed, to prevent horse owners choosing vets that don’t challenge owners about their horses’ nutrition. Feed companies can also play an important role in tackling this issue, although many feed companies already offer appropriate nutrition for a range of horses and exercise situations. Better owner education, based on existing good research, would ensure the right nutritional choices are made for individual horses.
Inappropriate stabling /turnoutWelfare of horses is compromised when the amount of time spent at pasture/stabled does not meet their individual needs, when they are kept in social isolation or when they are exposed to unsuitable grazing conditions. Welfare problems associated with incorrect stabling/turnout affect large numbers of horses for a long time with variable levels of suffering.
Although all horse owners make choices relating to the amount and type of stabling and turnout experienced by their horses, livery yard owners could play a role in addressing this issue. For example, by encouraging different approaches to management, including group housing and the use of all-weather turnout facilities. Strengthening legislation is another possible way for improvement but a ‘one size fits all’ approach would be inappropriate. For example, for some horses, turn out to pasture may not always be suitable.
Delayed deathHorses may be kept alive inappropriately resulting in firstly, prolonging welfare problems, such as continued suffering of a horse in pain. This affects relatively large numbers of horses, for short periods of time with the severity of suffering often being severe. Secondly, an increased risk of suffering, for example where horses are unwanted by their owners, become low value and subsequently aren’t cared for well.
One way for improvement could be by putting pressure on the EU to make changes to the passport regulations. In particular, legislation changes that would enable horses who had received medications, including Phenylbutazone, to be slaughtered to enter the human food chain after a six month withdrawal period. In addition, challenging negative attitudes of horse owners towards timely euthanasia is important.
The research, undertaken over a four year period, was to understand the welfare status of horses in England and Wales, identify priority welfare issues and explore horse owner and industry experts’ perceptions of these issues.
Stakeholders from across the equine industry contributed to the research: from vets to farriers and welfare charities to governing body representatives, participants represented a wide-reaching cross section of horse care roles and responsibilities.
The step-by-step guide offers guidelines to help farmers improve their herd's mobility.
It highlights the importance of implementing a robust and ongoing treatment plan to improve cow comfort and reduce lameness in the short-term, which will lead to increased production and herd welfare in the longer-term.
The guide includes advice on reviewing a whole herd by an independent RoMS (Register of Mobility Scorers) accredited mobility scorer, seeking veterinary advice or contacting a mobility mentor (someone who has been trained to deliver the ADHB Healthy Feet Programme) if lesions are identified, treating within 48 hours of identification with a combination of trim, block, topical antimicrobial spray and non-steroidal anti-inflammatory (NSAID), as appropriate, and the importance of ongoing treatment, prevention and monitoring every fortnight.
The guide also includes tips for the successful use of NSAIDs, which include the importance of using a NSAID with a zero milk withhold.
There are four lameness management videos which were produced in collaboration with James Wilson BSc (Hons) PhD, a foot health consultant from Herd Health Consultancy and include contributions from Alex Burrows, professional foot trimmer and Chair of the National Association of Cattle Foot Trimmers (NACFT), Dave Bacon, a dairy farmer from Gleadthorpe Farm in Nottinghamshire, Shannon Trinder, assistant herdsperson at Gleadthorpe Farm and Harry Walby BVetMed MRCVS, veterinary surgeon and ruminant technical advisor at Ceva Animal Health.
They cover the benefits of regular mobility scoring, prioritising mobility and lameness prevention in heifers and maintaining lameness management success with practical and effective lameness treatment and prevention programmes.
www.wavegoodbyetopain.co.uk/pdf/step-by-step-guide.pdf.www.wavegoodbyetopain.co.uk/training-videos.html.
Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins associated with both inflammation and pain, COX-1 has a pivotal role in maintaining normal physiological function, so inhibiting this enzyme may have an increased risk of side effects e.g. gastric ulceration. Merial says Equioxx is the only NSAID that is highly COX-2 selective (up to 643 times more selective for COX-2 than COX-1), acting to reduce pain and inflammation but without affecting the COX-1 enzyme at therapeutic levels.
Equioxx contains the active ingredient firocoxib, and Merial says it is proven to be effective at reducing chronic lameness in horses. Appearing in blood plasma within 30 minutes of oral dosing, its pharmacokinetic profile allows once daily dosing. Field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Equioxx is available as either a low dose injectable solution or a palatable oral paste.
For more information contact Merial Customer Services on 0870 6000 123
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2010 until 31st March 2011 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
According to the company, data from the Barren EweCheck and FlockCheck 2010 schemes showed that 86% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
The company anticipates full availability of Toxovax in 2011 and says its Barren EweCheck blood sample submission pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
The Government has been forced to scrap plans for compulsory dog insurance less than a two weeks since they were revealed in leaked Defra documents.
Environment Secretary Hilary Benn has now ruled out the idea.
Apparently, the climbdown followed protests that compulsory insurance was no more than a 'dog tax' which would do nothing to curb the problem of dangerous dogs.
There's a certain irony in the way the story was reported in The Sun newspaper, with the headline: 'Labour forced to ditch pet plan'.
Indeed!
Ronnie (pictured right) will look at quality control and artefacts of sample quality and review the effects of different pathologies. By examining analyser output, he'll demonstrate how abnormalities of cells and plasma may affect measured parameters and their indices.
Using images, photomicrographs and video links, he'll move onto explain the techniques and equipment needed to complement analytical automation in order to confirm results quality.
Ronnie said: "“We now have more near patient testing in veterinary haematology than ever before. Quality is key to best practice and ultimately superior patient care. Sod’s Law states that ‘if something can go wrong, it will!’, so along the way to your generating a Complete Blood Count, it pays to be aware of some of the pitfalls that you may encounter.
“One should never underestimate the value of gross exam and simple methods that can be used to ensure sample quality and results accuracy. Seeing is believing after all!”
There will also be an open Q&A session with Ronnie after the presentation, so attendees are invited to bring any questions on all things haematology.
To register for the webinar, visit: https://register.gotowebinar.com/register/2458623866746094093
Avid has released a new version of it's microchip registration system, which offers a significantly enhanced statistical analysis of the microchipping done at your practice.
The new MicroChip Plus section of the site is specifically for implanters, and contains the following:
Avid says the registration system, which has built-in postcode software, can now re-use more registration details, so that registering a complete litter will take less time. This is especially important when microchips are being registered for or by breeders.
Denise Chaloner, Manager at Avid said: “Avid MicroChip Plus gives our customers more control of how they manage pet microchipping within their organisation. Listening to feedback has inspired Avid to develop a more tailor-made and efficient system for the end user, also enabling the generation of reports, statistics and targets”.
Customers with supporting practice management systems may register microchips directly from their software using VetXML and VetEnvoy.
For more information contact Avid on freephone 0800 652 7 977 or email sales@avidplc.com
The survey was held between the 1st and 5th May and was sent to the 3,139 UK veterinary practices for which the RCVS holds a unique email address. In total it gathered 251 responses (a response rate of 8%) compared to the 532 responses to the initial survey conducted between 3rd and 7th April (a response rate of 17%).
The main changes compared to last month's survey were:
Lizzie Lockett, RCVS CEO, said: "This latest survey has identified some positive trends in terms of a slight uptick in business, including turnover, and fewer incidences of staff having to take time off with COVID or COVID-like symptoms.
“I am glad to see that the framework we published in April has, so far as we can see, provided veterinary professionals with greater guidance and reassurance regarding the fact that if it is feasible to do something safely under social distancing guidelines, then they can go ahead, if they choose to.
"We left plenty of scope for veterinary professionals to use their clinical judgement as to what services actually offer, depending on their facilities, level of staffing, availability of protective equipment, local disease pressures and so on.
"However, it is also clear that we are, by no means, out of the woods and that veterinary businesses are still struggling financially, with some of them reporting a very acute impact of the coronavirus and the associated restrictions on their businesses.
“We will continue to monitor the situation via these regular surveys, with the next one planned for early June. I would urge as many practices as possible to continue to complete them, so that we can build up a stronger evidence-base on how veterinary businesses have been affected. This information is not only vital for our own policy decisions but also allows us to present a stronger case to the Government and other public bodies where we wish to influence the decisions they make that will impact the veterinary professions and businesses.”
The survey results can be read in full at www.rcvs.org.uk/coronavirus-resources.
The hands-on course, which is worth 7 CPD hours, has been organised by Dr Nicola M Parry, Recognised Specialist in Pathology at the University of Surrey School of Veterinary Medicine. It will combine lectures, practicals, and a Q&A session to enable delegates to carry out a post-mortem, identify common (and not so common) pathologies, and draw conclusions about the cause of death.
The morning lectures will provide an overview of techniques that focus on how to approach the post-mortem examination of the adult horse and the foetus/foal, as well as how to examine the placenta. Potential findings will be discussed as well as some pitfalls to avoid during the post-mortem examination, and how to optimise sample submission. The lectures will be recorded, enabling sessions to be reviewed later.
Delegates will spend the afternoon in the post-mortem room, examining macroscopic specimens and learning practical approaches to a post-mortem examination in the field, and the collection of key specimens. The day will close with a Q&A session.
Speakers Dr Fabio Del Piero from the Louisiana State University and Dr Marvin J Firth from the University of Surrey will help delegates to:
Sarah Gaspar, the Learning Manager at BEVA said: “If you have ever been called out to a dead horse to find a distraught owner and not been sure how to identify the cause, this course is for you. We can’t remember any course ever having been run on this topic in the UK before; it is likely to be very popular so be quick to book.”
To find out more and to book click here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1582
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
Designed with the RCVS Standards and Advice team, the ‘Client confidentiality’ course explains the steps veterinary teams need to take when deciding whether or not to make a disclosure, and how to remain compliant with their professional obligations under the Code of Professional Conduct.
Senior Standards and Advice Officer, Victoria Price said: “Deciding to breach confidentiality is often a difficult decision with no right or wrong answer.
"The course should help learners to feel confident about what to consider in order to make justified and well-supported decisions.”
The course takes around one hour to complete.
academy.rcvs.org.uk
In short, it’s a system which gives clients a breakdown of the options you have recommended, with an explanation of the procedure or treatment, potentially the pros and cons, and the price.
When time permits, this allows the client to consider their options at home, on their own, with the information in front of them, taking away the pressure that sometimes comes with having to make these decisions in front of a veterinary professional.
The system works as a standalone web-based service at present, but integrations with VetIT and Lupa are in development.
Practices can configure the software with their own information about treatment and procedures, but VetConsent has also teamed up with Visiocare and Vetlexicon to provide graphically rich material to help the client understand even better.
The service costs £40 per vet per month.
Chief Veterinary Officer, Nick Lloyd MRCVS said: “We’re confident that the time-savings alone will more than cover the cost of the service, but even more importantly, it improves the service you offer clients and ensures that you’ve covered all the bases in getting informed consent.”
https://vetconsent.com
William McEwan BSc MRes PhD, now working at the MRC-Laboratory of Molecular Biology in Cambridge, has been awarded the ABCD and Merial Young Scientist of the Year Award 2010 for his work on the replication and cross-species transmission of feline immunodeficiency virus infection in domestic cats and lions, and the restriction factors in these species in particular.
Dr McEwan said: "Understanding the means by which host species are able to prevent viral replication gives us insight to the mechanisms of infection and may allow us to engineer therapy based on similar mechanisms or by enhancing immune responses."
The award was presented by Professor Marian C. Horzinek, Chair of the European Advisory Board on Cat Diseases (ABCD) and of the award jury. He said: "William McEwan presented a very original, high quality paper. His research has indicated the ability of hosts to potently restrict retroviral replication - given sufficient evolutionary time. It has also highlighted felids as a taxon that is potentially highly prone to cross-species transmission of immunodeficiency viruses".
The ABCD and Merial Young Scientist Award, created in 2008 and worth 1000 €, is funded by Merial and is presented to a young scientist in veterinary or biomedical science, who has made an original contribution in the field of feline infectious diseases and/or immunology. Applicants should have published their findings in a journal listed in PubMed or Web of Science or have had them accepted by another recognised assessing body.
Candidates should be based in Europe, have completed a veterinary or biomedical curriculum, and be under 35 years of age at the time of application. Applications for the 2011 award are now being invited (deadline 15 January 2011). For more information, visit: www.abcd-vets.org
Hosted by Nick Steele, National Consulting Manager at Zoetis and Rachael Whittle, a business coach specialist, the course will present the best techniques to analyse mixed personalities that cause problematic situations, allowing staff to deal with difficulties that may occur on a daily basis. Nick will use his knowledge from working at the world’s largest global animal health company, while Rachael will use her experience in business training and coaching to help anyone that works with people on a daily basis manage these daily challenges, using common examples from their own background.
For the chance to win a free place at this event, send an email with your name, the name of your veterinary practice and the reason attending this course will help grow your practice’s business to royalcaninvet.gbr@royalcanin.com.
Royal Canin will select three applicants at random, and will inform the winners via email, by Thursday 30 June.
Places on the course can also be booked by calling 01453 872731 or by visiting www.spvs-vpma-events.co.uk. Workshops cost £265 plus VAT for non-members and £190 plus VAT for VPMA and SPVS members (group/ bulk booking discounts are also available). Cost includes CPD certificates, lunch and refreshments.
During a welcome reception, leaders and representatives of the veterinary profession were given tours of the facility and shown the advanced surgical training and ultrasound equipment available.
The wet-lab is equipped with 13 electrically-adjustable surgical tables, each with their own operating light and an audio-visual (a/v) system connecting them to the lecturer. The a/v system enables the lecturer to carry out demonstrations of procedures and to provide individual or group guidance to delegates practising surgical and other practical techniques.
Delegates are able to use the latest surgical and diagnostic equipment, including IM3 dental equipment, Logic E ultrasound machines and new surgical instrumentation for a range of orthopaedic and soft tissue procedures.
Improve's Managing Director, David Babington MRCVS, said: "Newly qualified vets have a huge need for additional training in practical skills and this demand extends into their ongoing professional life as new techniques are developed and existing ones refined.
"We already offer practical training facilities to delegates attending our training programmes at our HQ in Swindon but wanted to make it easier for vets and nurses in the north of the UK to access these facilities. This new 'wet-lab' offers an ideal training environment for our delegates to accelerate their learning and take new skills back to their practice."
He added: "Learning new techniques, whether surgical or diagnostic, is a proven way to boost practice profitability because it reduces the need to refer more complex cases. We hear from many of those who have trained with us that their increased skillset has enhanced their job satisfaction and increased the volume of cases they treat. In many cases, the training has paid for itself many times over. We are excited at the prospect of helping even more veterinary professionals to advance their skills."
Janssen Animal Health has launched a range of skincare products - Cavalesse® and Cavalesse® Topical - to help maintain and support a healthy skin in horses prone to summer skin allergies.
According to the company, summer skin allergies, including sweet itch, which is caused by reactions to bites from Culicoides midges, can be serious and frustrating conditions that affect three to five per cent of all horses in the UK. These allergies can be difficult to manage and are often a real challenge for both horse owners and vets alike.
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including Nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. The supplement helps horses maintain a healthy skin by reducing histamine release within the skin, moderating the excessive immune response within the skin, reducing anti-inflammatory reactions and suppressing antigen induced transformation.
To complete the Cavalesse skin management range, Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
Helen Goldberg, marketing manager at Janssen Animal Health said: "Summer skin allergies, such as sweet itch, are frustrating conditions that can be difficult to treat. To help prevent the disease, horses are often fully blanketed while out at grass, given limited access to pasture or covered with insect repellents, while treatment has included antihistamines and corticosteroids which can have side-effects.
"Only available via veterinary wholesalers, the Cavalesse range of products will enable owners to protect their horses from the inside, whilst maintaining a healthy skin from the outside."
2ml of Cavalesse should be administered to horses and ponies weighing less than 500kg daily, while horses weighing more than 500kg should be given 3ml per day. Cavalesse Topical should be applied to the skin according to requirements.
For further information, please contact your Janssen Animal Health account manager or phone 01494 567555.
Virbac is running a special promotion through which UK-based practitioners who order from the company's reproductive product range can claim a free copy of the evidence-based book Clinical Canine and Feline Reproduction by Margaret V. Root Kustritz.
The book covers 100 separate questions across a range of reproductive issues, and currently retails for £47.99.
Virbac product manager Chris Geddes MRCVS said: "We offered this book as part of a promotion in 2010 and it proved extremely popular. As a result we thought we would give vets another chance to get a free copy."
As the Assistant Dean at the Minnesota College of Veterinary Medicine, Margaret V. Root Kustritz is a leading figure in feline and canine reproduction and one of the world's most renowned experts in reproduction. Mr Geddes said: "The book is based on the questions veterinary surgeons have asked her over the years, and so is a valuable reference tool for any vet."
Numbers are limited, and the book is available on on a 'first come first served' basis. Anyone interested should either contact their territory manager or call Virbac on 01359 243243.
Krka says Arocenia provides fast, broad-spectrum anti-emetic efficacy with a 24-hour duration of action following a single daily dose.
It can be administered intravenously or subcutaneously and is supplied in 20 ml multi-dose vials, allowing up to 40 punctures per vial and a 60-day open vial shelf life.
Renzo Di Florio, Krka’s Technical Veterinary Adviser, commented “Vomiting is one of the most common presenting signs in small animal practice, and maropitant is a medication you’ll find on just about every vet’s dispensary shelf. With Arocenia, we’re adding a cost-effective formulation to the available options.”
https://www.krka.co.uk//products/our-products/animal-health/arocenia-10mgml-solution-for-injection
BVA has announced that it is launching a pilot of VETS.TV, and invites you to come and preview the service at its stand at BSAVA. Anyone willing to surrender their name and email address will also be entered into a prize draw to win an HP 530 Celeron M 440 laptop computer.
VETS.TV is an internet television site run jointly by the BVA and Ten Alps Publishing which will be available via a microsite of http://www.bva.co.uk/. The pilot includes custom-made videos on MRSA, litigation and stress management, a series of interviews with key veterinary figures and a number of specially acquired programmes.
Free-range table-birds being reared from slower growing breeds need a different vaccination regime from that of faster-growing broilers, when being immunised against Gumboro disease.
This previously-unknown fact has emerged from laboratory and field trials, involving several hundred thousand birds on farms throughout the UK, carried out by Lohmann Animal Health in conjunction with poultry vets.
"When using a ‘hot' vaccine conventional broilers in the UK are normally vaccinated at around 14-16 days when their maternal immunity is waning," said Adam Goddard, Lohmann's UK sales consult. "However, we've found this maternal immunity lasts longer in the slow-growing breeds which are reared both indoors and out."
Realistically, the correct day of vaccination for free-range table-birds is more likely to be achieved by using the vaccine date predictions for broiler-breeders, rather than that of the broiler, under the Deventer formula, which gives calculations for different types of bird.
He therefore advises producers to consult their vets who can take blood samples to get an accurate prediction regarding optimum timing of vaccination with their own particular flocks.
"Our trials have shown that, in general, and depending upon the breed used, the decline in maternal immunity is delayed - perhaps for 4-5 days. So, in order to get a better ‘take', we recommend vaccinating these birds later or using an IBD vaccine that ‘takes' in the presence of high maternal immunity." said Mr Goddard.
Gumboro disease - also known as Infectious Bursal Disease - can cause severe losses in chickens and outdoor-reared birds are more susceptible to the disease due to environmental influences.
Earlier this year Lohmann Animal Health launched a new ‘hot' vaccine, classified as an ‘intermediate plus' against the very virulent form of Gumboro disease. The company says that because of its ability to break through high levels of maternal antibodies, it allows vaccination to take place earlier than with other existing vaccines.